The PIN network began in 2007 as PatientCrossroads and joined forces with Invitae in 2016. News from before 2017 can be viewed below. For the latest news, please visit the Invitae blog.

Invitae acquires patient-centered data company AltaVoice, creating new offerings to advance research and access to care for patients with inherited and rare diseases

SAN FRANCISCO, January 6, 2017 -- Invitae Corporation (NYSE: NVTA), one of the fastest growing genetic information companies, today announced it has acquired AltaVoice (formerly PatientCrossroads), a privately owned, patient-centered data company with a global platform for collecting, curating, coordinating, and delivering safeguarded data from patients and clinicians. The acquisition, complemented by several other unique partnerships, expands Invitae's Genome Network, designed to connect patients, clinicians, advocacy organizations, researchers, and therapeutic developers to accelerate the understanding, diagnosis, and treatment of hereditary disease.

Read More

AltaVoice Shares Data on Diseases from its Patient Insights Network

AltaVoice(SM) formerly PatientCrossroads) announced it has launched its new website which includes a series of “Patients Living With” infographics covering a variety of diseases. The home page features two diseases and a link that makes it possible to explore the disease directory in alphabetical order.

Site visitors may select a topic of interest and enter their contact information to view several informative infographics. The home page of the site currently features Patients Living with Eosinophilic Esophagitis (EoE) and Adrenal Insufficiency. These graphics tell a story from the onset of symptoms to time of diagnosis through treatment. They are designed to help researchers understand the size of the patient population and current age and gender of the members of the Patient Insights Networks for each disease.

PatientCrossroads Rebrands as AltaVoice

New Name Underscores Focus on Delivering Insights to Enable Drug Developers to Meet FDA Mandates for More Patient-Centered Drug Development

PatientCrossroads announced it has changed the company name to AltaVoice℠ and created a new brand identity aligned with its Mission: Amplifying the voice of patients to optimize the search for better treatments for disease. The move reflects the latest product innovations designed to deliver patient insights to drug developers faster, and for far less, than traditional registries and CRO organizations. Read More

Let's Save Lives: Registry for the Most Common Cancer Launches During November Lung Cancer Awareness Month

The Bonnie J. Addario Lung Cancer Foundation (ALCF), the American Lung Association (ALA) and AltaVoice (formerly known as PatientCrossroads) today announced the new Lung Cancer Registry. The Registry is a place to gather and store detailed information for patients with lung cancer, which kills more Americans each year than the next three most frequent types of cancers combined.

Read More

SerPaciente Debuts First Continent-Wide Network to Gather Patient Insights, Starting with Chronic Myelogenous Leukemia (CML) and Multiple Myeloma

Previews plans to unite additional cancer organizations under 21st century global data collection model.

PatientCrossroads announced the expansion of its global Patient Insights Network (PIN) to include SerPaciente, the first patient-centered data collection program across an entire continent. At the All Together Against Cancer Congress in Brazil, SerPaciente, Inc. debuted its online interactive Patient Insights Network, a platform that puts patients at the center of a 21st century model for collecting, curating, coordinating and delivering data from patients and clinicians faster, and for far less, than traditional registries and CRO organizations.  ​Read More